• Drug Class: Anti Diabetic Type 2, SGLT2 inhibitors
• Chemical Formula: C24H35ClO9
• CAS Number: 960404-48-2
• Indications: Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated:
- To reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression.
- To reduce the risk of CV death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure.
- To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established CV disease or multiple CV risk factors.
- As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.